Kobayashi Pharma Shareholders Reject Hong Kong Fund's Proposals
Osaka, Feb. 19 (Jiji Press)--Kobayashi Pharmaceutical Co. shareholders voted down proposals by Hong Kong-based investment fund Oasis Management Co. at their extraordinary meeting in Osaka on Wednesday.
Oasis, whose stake in the Japanese maker and seller of over-the-counter drugs and supplements tops 10 pct, proposed that lawyer Yoshio Nakamura and two others be appointed as outside board directors and that the high-profile health damage, including fatal cases, linked to "benikoji" red yeast supplements be reinvestigated under a more independent framework.
(2025/02/19-18:47)
To read a full story, please click here to find out how to subscribe.
BUSINESS
-
03/17 21:31 (Update) TEPCO Aims to Restart Niigata N-Reactor in FY 2025 -
03/13 21:44 (Update) Couche-Tard Asks Seven & i to "Adequately Consider" Buyout - 03/13 21:24 Damage from Aeon Card Fraud in Japan Reaches 9.9 B. Yen
- 03/13 18:39 Japan's Mizuho Bank Opening New Type of Branch
- 03/13 18:07 Couche-Tard Founder Asks Seven & i to "Adequately Consider" Buyout
- 03/12 20:25 Japanese Apparel Industry Seeking Sustainable Fashion
- 03/12 20:15 Electronic Dictionary Market Shrinking in Japan
- 03/12 10:36 Toyota to Release New Electric SUV in Europe This Year
- 03/11 23:32 (Update) Uchida to Step Down as Nissan CEO
- 03/11 18:30 Uchida to Step Down as Nissan CEO
- 03/11 16:06 Couche-Tard Disappointed with Seven & i Takeover Talks
- 03/10 22:45 Seven & i Suggests Couche-Tard Sell U.S. Stores for Takeover
- 03/03 13:52 Units of Japan Tobacco, Others Agree to Settle Canadian Litigation
